Inmune Bio INMB
NASDAQ INMB
$2.32 +0.16 (+7.41%)
At close: Aug 21, 2026 · 4:00 PM EDT

Inmune Bio (INMB) Shares Outstanding (Diluted) (2021 - 2026)

Inmune Bio (INMB) Shares Outstanding (Diluted) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 255.20 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 106.00 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 64.41 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 398.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 115.80 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 138.28 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 241.70 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 217.35 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 556.90 Mn
10 Inmune Bio 61.59 Mn 43.18 Mn - 26.72 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 26.72 Mn
Mar 31, 2026 26.59 Mn
Dec 31, 2025 24.76 Mn
Sep 30, 2025 26.59 Mn
Jun 30, 2025 23.30 Mn
Mar 31, 2025 22.50 Mn
Dec 31, 2024 19.94 Mn
Sep 30, 2024 20.19 Mn
Jun 30, 2024 19.31 Mn
Mar 31, 2024 18.03 Mn
Dec 31, 2023 17.98 Mn
Sep 30, 2023 18.01 Mn
Jun 30, 2023 17.95 Mn
Mar 31, 2023 17.95 Mn
Dec 31, 2022 17.93 Mn
Sep 30, 2022 17.95 Mn
Jun 30, 2022 17.95 Mn
Mar 31, 2022 17.87 Mn
Dec 31, 2021 16.13 Mn
Sep 30, 2021 17.33 Mn